FierceHealthcareFierceHealthITFierceHealthFinanceHospital Impact   FiercePharmaFierceBiotechFierceSarbox
Syndicate content

Harvard University Professor news from FierceHealthcare

Most Popular Harvard University Professor story
Related Tags Food and Drug Administration (FDA)   Fda Approval Process   drugs   Daniel Carpenter
Tools

News

SPOTLIGHT: Revised study still finds that FDA approval rush may cause harm

July 3, 2008 — 1:26am ET | By Anne Zieger
Harvard University professor Daniel Carpenter has come out with a revised version of a study concluding that drugs moving too quickly through the FDA approval process are more likely to be linked to... Read more...